124 related articles for article (PubMed ID: 38599607)
1. Bardoxolone methyl prevents metabolic dysfunction-associated steatohepatitis by inhibiting macrophage infiltration.
Onuma K; Watanabe K; Isayama K; Ogi S; Tokunaga Y; Mizukami Y
Br J Pharmacol; 2024 Apr; ():. PubMed ID: 38599607
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure.
Tian C; Gao L; Zhang A; Hackfort BT; Zucker IH
J Pharmacol Exp Ther; 2019 Dec; 371(3):642-651. PubMed ID: 31601682
[TBL] [Abstract][Full Text] [Related]
3. Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications.
Walsh J; Jenkins RE; Wong M; Olayanju A; Powell H; Copple I; O'Neill PM; Goldring CE; Kitteringham NR; Park BK
J Proteomics; 2014 Aug; 108(100):171-87. PubMed ID: 24859727
[TBL] [Abstract][Full Text] [Related]
4. Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.
Wang YY; Yang YX; Zhe H; He ZX; Zhou SF
Drug Des Devel Ther; 2014; 8():2075-88. PubMed ID: 25364233
[TBL] [Abstract][Full Text] [Related]
5. A Point Mutation at C151 of
Gatbonton-Schwager T; Yagishita Y; Joshi T; Wakabayashi N; Srinivasan H; Suzuki T; Yamamoto M; Kensler TW
Mol Pharmacol; 2023 Aug; 104(2):51-61. PubMed ID: 37188495
[TBL] [Abstract][Full Text] [Related]
6. Bardoxolone methyl inhibits the infection of rabies virus via Nrf2 pathway activation in vitro.
Chi YL; Xie Y; Liu SQ; Zhu WY
Virol J; 2023 Nov; 20(1):258. PubMed ID: 37950261
[TBL] [Abstract][Full Text] [Related]
7. The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic-acid methyl ester has potent anti-diabetic effects in diet-induced diabetic mice and Lepr(db/db) mice.
Saha PK; Reddy VT; Konopleva M; Andreeff M; Chan L
J Biol Chem; 2010 Dec; 285(52):40581-92. PubMed ID: 20956520
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.
Thimmulappa RK; Fuchs RJ; Malhotra D; Scollick C; Traore K; Bream JH; Trush MA; Liby KT; Sporn MB; Kensler TW; Biswal S
Antioxid Redox Signal; 2007 Nov; 9(11):1963-70. PubMed ID: 17822364
[TBL] [Abstract][Full Text] [Related]
9. CDDO-Me Inhibits Microglial Activation and Monocyte Infiltration by Abrogating NFκB- and p38 MAPK-Mediated Signaling Pathways Following Status Epilepticus.
Kim JE; Park H; Lee JE; Kang TC
Cells; 2020 May; 9(5):. PubMed ID: 32370011
[TBL] [Abstract][Full Text] [Related]
10. In vitro study on effect of bardoxolone methyl on cisplatin-induced cellular senescence in human proximal tubular cells.
Kurosaki Y; Imoto A; Kawakami F; Ouchi M; Morita A; Yokoba M; Takenaka T; Ichikawa T; Katagiri M; Nielsen R; Ishii N
Mol Cell Biochem; 2022 Mar; 477(3):689-699. PubMed ID: 34973124
[TBL] [Abstract][Full Text] [Related]
11. The Methyl Ester of 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid Reduces Endometrial Lesions Development by Modulating the NFkB and Nrf2 Pathways.
Siracusa R; D'Amico R; Cordaro M; Peritore AF; Genovese T; Gugliandolo E; Crupi R; Impellizzeri D; Cuzzocrea S; Fusco R; Di Paola R
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924360
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids.
Borella R; Forti L; Gibellini L; De Gaetano A; De Biasi S; Nasi M; Cossarizza A; Pinti M
Molecules; 2019 Nov; 24(22):. PubMed ID: 31766211
[TBL] [Abstract][Full Text] [Related]
13. CDDO-Me Attenuates Vasogenic Edema and Astroglial Death by Regulating NF-κB p65 Phosphorylations and Nrf2 Expression Following Status Epilepticus.
Kim MJ; Park H; Choi SH; Kong MJ; Kim JE; Kang TC
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31574956
[TBL] [Abstract][Full Text] [Related]
14. Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells.
Wang YY; Yang YX; Zhao R; Pan ST; Zhe H; He ZX; Duan W; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():993-1026. PubMed ID: 25733817
[TBL] [Abstract][Full Text] [Related]
15. The Triterpenoid Nrf2 Activator, CDDO-Me, Decreases Neutrophil Senescence in a Murine Model of Joint Damage.
Amirova KM; Dimitrova PA; Leseva MN; Koycheva IK; Dinkova-Kostova AT; Georgiev MI
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240121
[TBL] [Abstract][Full Text] [Related]
16. The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis.
Kulkarni AA; Thatcher TH; Hsiao HM; Olsen KC; Kottmann RM; Morrissette J; Wright TW; Phipps RP; Sime PJ
PLoS One; 2013; 8(5):e63798. PubMed ID: 23741300
[TBL] [Abstract][Full Text] [Related]
17. CDDO-Me Distinctly Regulates Regional Specific Astroglial Responses to Status Epilepticus via ERK1/2-Nrf2, PTEN-PI3K-AKT and NFκB Signaling Pathways.
Kim JE; Park H; Kang TC
Antioxidants (Basel); 2020 Oct; 9(10):. PubMed ID: 33096818
[TBL] [Abstract][Full Text] [Related]
18. Bardoxolone methyl ameliorates osteoarthritis by inhibiting osteoclastogenesis and protecting the extracellular matrix against degradation.
Yang R; Guo Y; Zong S; Ma Z; Wang Z; Zhao J; Yang J; Li L; Chen C; Wang S
Heliyon; 2023 Feb; 9(2):e13080. PubMed ID: 36798782
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268.
Liby K; Risingsong R; Royce DB; Williams CR; Yore MM; Honda T; Gribble GW; Lamph WW; Vannini N; Sogno I; Albini A; Sporn MB
Clin Cancer Res; 2008 Jul; 14(14):4556-63. PubMed ID: 18628471
[TBL] [Abstract][Full Text] [Related]
20. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT
Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
